NCT06796673
Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases
Enrolling by Invitation
Not specifiedAges 18+ObservationalGreater Houston Retina ResearchInvestigator-initiated
~10,000 participants
Updated 2025-01-28 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To quantify levels of disease state biomarkers implicated in the pathogenesis of various retinal and systemic pathologies
Measured over Baseline
Conditions
Where it's being run
3 sites across 1 statesTexas3
Study leadership
- Charles C. Wykoff, MD, PhD · PRINCIPAL_INVESTIGATOR · Greater Houston Retina Research
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- To quantify levels of disease state biomarkers implicated in the pathogenesis of various retinal and systemic pathologiesBaseline
An analysis of the ocular fluids and tissues of patients with various vitreoretinal diseases would allow for the development of a deeper understanding of the processes that contribute to their onset and may ultimately provide insight in methods to refine treatment and management options.